Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs MasTec Inc (MTZ) Price & Performance

Axogen IncTrade
MasTec IncTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs MasTec Inc — how do they compare? Axogen Inc trades at $39.4 (market cap $2.06B), while MasTec Inc trades at $365.73 (market cap $28.85B). The key difference: MasTec Inc is far larger — about 14× Axogen Inc's market cap. Which is the better fit depends on your goals.

AXGNMTZ
Market Cap
$2.06B$28.85B
Sector
TechnologyTechnology
52-Week High
$46.19$437.51
52-Week Low
$11.28$171.92
Enterprise Value
$1.98B$31.60B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.

The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.

MasTec Inc

MasTec (MTZ) trades at $360.21, down 3.4% on the day, with a bearish technical signal despite strong fundamental performance. The company recently announced a $1.65 billion acquisition of The Superior Group to expand its data center infrastructure capabilities, boosting its position in AI-driven markets. Recent quarterly earnings have consistently beaten expectations, with Q1 2026 showing 34% revenue growth and 73% adjusted EBITDA growth, supported by a record $20.3 billion backlog.

Wall Street maintains strong bullish sentiment with 89% buy ratings and a $481.77 consensus price target suggesting 34% upside potential. Key risks include integration challenges from the large acquisition and premium valuation metrics. The stock's current weakness presents a potential buying opportunity for investors bullish on infrastructure spending trends.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About MasTec Inc

MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.

Read more on MTZ